HAVCR2 and neoplasm: As shown in Figure 4A, the sequential administration of anti-PD-1 and anti-Tim-3 antibodies combined with the Anchored GM-CSF vaccine further suppressed tumor growth and caused tumor regression in 62.5% of the treated mice.